Literature DB >> 8848142

Immunolesioning of basal forebrain cholinergic neurons facilitates hippocampal kindling and perturbs neurotrophin messenger RNA regulation.

M Kokaia1, I Ferencz, G Leanza, E Elmér, M Metsis, Z Kokaia, R G Wiley, O Lindvall.   

Abstract

The immunotoxin 192 IgG-saporin induces an efficient and specific lesion of low-affinity nerve growth factor receptor-bearing cholinergic neurons in the basal forebrain. Intraventricular injection of 192 IgG-saporin, which caused a complete loss of cholinergic afferents to the hippocampus and neocortex and a partial denervation of amygdala and piriform cortex, was found to markedly facilitate the initial stages of seizure development in hippocampal kindling. In contrast, the progression of kindling process from focal to generalized seizures was not affected. In situ hybridization demonstrated that basal levels of brain-derived neutrotrophic factor messenger RNA in the hippocampal formation and piriform cortex were significantly decreased by the lesion, which also attenuated the seizure-induced increase of brain-derived neurotrophic factor messenger RNA expression in the hippocampus and frontal cortex. In the dentate gyrus, the 192 IgG-saporin lesion selectively reduced the upregulation of messenger RNAs for brain-derived neurotrophic factor exons I and III after a generalized seizure, whereas the increase of exon II messenger RNA was unchanged. The lesion abolished the seizure-evoked increase of nerve growth factor and TrkC messenger RNA levels and decrease of neutrophin-3 messenger RNA expression in dentate granule cells, while TrkB messenger RNA levels were not affected. We conclude that the basal forebrain cholinergic system (1) suppresses kindling epileptogenesis in the hippocampus, and (2) enhances both basal and seizure-evoked brain-derived neurotrophic factor synthesis in the hippocampal formation and some cortical areas through a specific pattern of activation of promoters within the brain-derived neurotrophic factor gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8848142     DOI: 10.1016/0306-4522(95)00384-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Alzheimer's disease and epilepsy: insight from animal models.

Authors:  Helen E Scharfman
Journal:  Future Neurol       Date:  2012-03-01

2.  A comparison of behavioural effects and morphological features of grafts rich in cholinergic neurons placed in two sites of the denervated rat hippocampus.

Authors:  E Hofferer; C Kelche; B Will; J C Cassel
Journal:  Exp Brain Res       Date:  1996-09       Impact factor: 1.972

3.  Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices.

Authors:  M Alkondon; E F Pereira; H M Eisenberg; E X Albuquerque
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

4.  Up-regulation of cation-independent mannose 6-phosphate receptor and endosomal-lysosomal markers in surviving neurons after 192-IgG-saporin administrations into the adult rat brain.

Authors:  Cheryl Hawkes; Doreen Kabogo; Asha Amritraj; Satyabrata Kar
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

5.  Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat.

Authors:  O Raineteau; K Fouad; P Noth; M Thallmair; M E Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 6.  Unexpected Effects of Acetylcholine Precursors on Pilocarpine Seizure- Induced Neuronal Death.

Authors:  Minwoo Lee; Bo Young Choi; Sang Won Suh
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

7.  Increased BDNF may not be associated with cognitive impairment in heroin-dependent patients.

Authors:  Xiaoqian Luan; Jingyan Tao; Jie Zhang; Ying Xie; Xiangyang Zhang; Hang Su; Jincai He
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Acute Down-regulation of BDNF Signaling Does Not Replicate Exacerbated Amyloid-β Levels and Cognitive Impairment Induced by Cholinergic Basal Forebrain Lesion.

Authors:  Marion T Turnbull; Zoran Boskovic; Elizabeth J Coulson
Journal:  Front Mol Neurosci       Date:  2018-02-22       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.